Αρχική World News Sacituzumab tirumotecan shows significant clinical benefit in advanced/recurrent endometrial cancer World News Sacituzumab tirumotecan shows significant clinical benefit in advanced/recurrent endometrial cancer Από Ogkologos - 26 Οκτωβρίου, 2026 8 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR GPRC5D Is An Active Immunotherapeutic Target in Multiple Myeloma 5 Οκτωβρίου, 2022 Mom’s Topless Photo Is Supposed To Encourage Breastfeeding, But Some Think... 19 Μαρτίου, 2019 Is there a right way to check your body for cancer? 29 Μαρτίου, 2022 ASCO20 Virtual Research Round Up Podcast: Breast Cancer, Sarcoma, and Supportive... 21 Ιουλίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic... Zooming in: Fine-tuning the picture to diagnose oesophageal cancer earlier New study to investigate breast cancer in ethnic minority groups Growing the Cancer Research Pipeline by Expanding Opportunities
